Stollery children's Hospital

Edmonton, Alberta T6G2B7

12 studies enrolling now · 56 studies all time

What they study most

AVB - Atrioventricular Block, Achondroplasia, Acute Kidney Injury, Acute Lymphoblastic Leukemia, Acute Respiratory Distress Syndrome, Adamantinomatous Craniopharyngioma, Anemia, Anemia, Sickle Cell, Anticoagulation, Atopic Dermatitis, COVID, Cardiac Arrest

Studies at this site

• A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease — Recruiting now
• Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors — Recruiting now
• A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease — Recruiting now
• TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II — Recruiting now
• Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease — Recruiting now
• ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma — Recruiting now
• Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ) — Recruiting now
• A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations — Recruiting now
• Quality of Pediatric Resuscitation in a Multicenter Collaborative — Recruiting now
• A Multicenter Multinational Observational Study of Children With Hypochondroplasia — Recruiting now
• A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension — Running, not enrolling
• A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine — Running, not enrolling
• Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV. — Running, not enrolling
• Efficacy and Safety of Erenumab in Pediatric Participants With Episodic Migraine — Running, not enrolling
• ARDS in Children and ECMO Initiation Strategies Impact on Neurodevelopment (ASCEND) — Running, not enrolling
• A Safety, Tolerability and Efficacy Study of TransCon hGH in Children With Growth Hormone Deficiency — Completed
• The Hunger Elimination or Reduction Objective (HERO ) Open -Label Extension (OLE) Trial — Stopped early
• ARD-101 for Treatment of PWS: The Hunger Elimination or Reduction Objective Trial — Stopped early
• Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I — Running, not enrolling
• A Research Study in Children Born Small and Who Stayed Small. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day — Running, not enrolling
• STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Loss — Running, not enrolling
• The ASCEND Study: Evaluating TMB-001 in the Treatment of RXLI or ARCI Ichthyosis — Completed
• A Research Study in Children With a Low Level of Hormone to Grow. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day (REAL4) — Completed
• DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2) — Running, not enrolling
• Prospective Clinical Assessment Study in Children With Achondroplasia (ACH) — Completed
• Evaluation of Maralixibat in Pruritus Associated With General Cholestatic Liver Disease (EXPAND) — Running, not enrolling
• Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine — Completed
• A Long-term Extension Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis — Completed
• Extension Study of Infigratinib in Children With Achondroplasia (ACH) — Enrolling by invitation
• Study of Infigratinib in Children With Achondroplasia — Completed
• A Study of Lorcaserin as Adjunctive Treatment in Participants With Dravet Syndrome — Stopped early
• Electronic KIDCLOT Interactive Thrombosis/Thrombophilia Education; A Quality Assurance Initiative — Running, not enrolling
• A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML) or With Ph+ Leukemias Resistant or Intolerant to Imatinib — Completed
• Evaluation of the Duration of Therapy for Thrombosis in Children — Completed
• A Pharmacokinetic Study of Ustekinumab in Pediatric Subjects With Moderately to Severely Active Crohn's Disease — Completed
• Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease — Completed
• Extended Access Program With Lorcaserin For The Treatment of Dravet Syndrome and Other Refractory Epilepsies — Available (expanded access)
• Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors — Running, not enrolling
• Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis — Completed
• Single-agent Erlotinib in Patients Previously Treated With Oral Etoposide in Protocol OSI-774-205 — Stopped early
• Apixaban for the Acute Treatment of Venous Thromboembolism in Children — Completed
• Selective Early Medical Treatment of Patent Ductus Arteriosus in Extremely Low Gestational Age Infants: A Pilot RCT — Status unconfirmed
• Vinblastine +/- Bevacizumab in Children With Unresectable or Progressive Low Grade Glioma (LGG) — Running, not enrolling
• Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia — Completed
• Pediatric Acute Kidney Injury in COVID-19 — Completed
• Age of Blood in Children in Pediatric Intensive Care Units — Completed
• Safety of Rivipansel (GMI-1070) in the Treatment of One or More Vaso-Occlusive Crises in Hospitalized Subjects With Sickle Cell Disease — Stopped early
• A Study of Safety, Tolerability and Pharmacokinetics of Apremilast (CC-10004) in Pediatric Subjects With Moderate to Severe Plaque Psoriasis — Completed
• A Phase 3 Study of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/MF) — Completed
• Melody PB1016 Surveillance Study — Completed